60 Degrees Pharmaceuticals, Inc.
SXTP
$4.62
-$0.42-8.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.35M | 973.70K | 791.50K | 670.50K | 451.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.35M | 973.70K | 791.50K | 670.50K | 451.80K |
| Cost of Revenue | 291.30K | 465.30K | 3.35M | 3.27M | 4.05M |
| Gross Profit | 1.06M | 508.30K | -2.56M | -2.60M | -3.59M |
| SG&A Expenses | 6.41M | 6.12M | 5.64M | 5.03M | 5.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.27M | 8.68M | 11.09M | 10.40M | 10.00M |
| Operating Income | -7.92M | -7.71M | -10.29M | -9.73M | -9.54M |
| Income Before Tax | -7.98M | -7.82M | -10.26M | -7.96M | -7.95M |
| Income Tax Expenses | 1.40K | 1.40K | 300.00 | 300.00 | 900.00 |
| Earnings from Continuing Operations | -7.98 | -7.82 | -10.26 | -7.96 | -7.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.60K | 6.60K | 6.90K | 8.60K | 38.60K |
| Net Income | -7.97M | -7.82M | -10.25M | -7.95M | -7.91M |
| EBIT | -7.92M | -7.71M | -10.29M | -9.73M | -9.54M |
| EBITDA | -7.84M | -7.64M | -10.24M | -9.68M | -9.50M |
| EPS Basic | -23.04 | -39.01 | -118.51 | -104.89 | -183.66 |
| Normalized Basic EPS | -13.51 | -22.98 | -71.43 | -61.37 | -106.11 |
| EPS Diluted | -23.04 | -39.01 | -118.51 | -104.89 | -183.66 |
| Normalized Diluted EPS | -13.51 | -22.98 | -71.43 | -61.37 | -106.11 |
| Average Basic Shares Outstanding | 1.85M | 1.05M | 732.70K | 454.00K | 239.40K |
| Average Diluted Shares Outstanding | 1.85M | 1.05M | 732.70K | 454.00K | 239.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |